1. Introduction
TRPM8 (transient receptor potential melastatin-8) was identified as a menthol receptor using an expression cloning approach [
1]. Menthol, a p-menthane-3-ol derived from the oil of peppermint, is known to induce a cold sensation. Analysis of the primary structure revealed that the receptor belongs to the TRP family of cation channels. The TRPM8 cDNA was simultaneously identified using a genomic DNA database search and PCR from a dorsal root ganglion cDNA library [
2]. The TRPM8 channel is activated by cold temperature and by cooling substances such as menthol, eucalyptol, and the synthetic “super-cooling agonist” icilin [
3]. TRPM8, like other TRP channels, is a polymodal sensor that integrates temperature and chemical sensations and play an essential role in thermosensation, as shown by the analysis of TRPM8-deficient mice [
4,
5,
6]. TRPM8 is found in sensory neurons, where it functions as a cold nociceptor which mediates nocifensive responses to noxious cold [
5,
6]. In addition, TRPM8 channels are involved in cold hypersensitivity triggered by nerve injury and inflammation. TRPM8 channels are also thought to be involved in the development of migraine, the development of tumors and other diseases [
7,
8,
9]. An anti-inflammatory role has also been proposed for TRPM8 [
10,
11].
Stimulation of TRPM8 channels triggers an intracellular signaling pathway that leads to a change in the gene expression pattern of the cells. We are interested in identifying the signaling molecules that are essential for the link between TRPM8 stimulation and gene transcription. Previous studies have shown that an influx of Ca
2+ ions is essential for the continuation of the signaling cascade after TRPM8 stimulation [
12]. The extracellular signal-regulated protein kinase ERK1/2 was identified as an intracellular signal transducter [
13]. In addition, calmodulin, calcineurin, and phospholipase C (PLC) β have been identified as important molecules that enable signal transduction from the plasma membran to the nucleus after TRPM8 channel stimulation [
14,
15]. However, the TRPM8-induced signaling cascade is far from being described in detail.
In this study, we focused our attention on the role of phosphatidylinositol 4,5-bisphosphate and trimeric G-protein subunits within the TRPM8-induced signaling cascade. Several reports have described the regulation of TRPM8 channels by phosphatidylinositol 4,5-bisphosphate [
16,
17,
18,
19,
20,
21], based on genetic tools that induced dephosphorylation of phosphatidylinositol 4,5-bisphosphate. We explored whether we could attenuate the signaling pathway of TRPM8 by interfering with the biosynthesis of phosphatidylinositol 4,5-bisphosphate.
In has been suggested that G-proteins modulate TRPM8 signaling, although this issue remained controversial. Stimulation of Gαq-coupled receptors activates phospholipase C, which catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate, thereby reducing phosphatidylinositol 4,5-bisphosphate levels. However, stimulation of Gαq-coupled receptors also leads to a rise in cytosolic Ca
2+ and activation of protein kinase C and other protein kinases that could influence channel activity. Direct binding of the Gαq subunit to TRPM8 has been shown [
22], but it is controversial whether the activated Gαq stimulates or inhibits TRPM8 [
22,
23] and whether phospholipase C is involved or not. In this study, we used pharmacological and genetic strategies to elucidate the roles of the α and βγ subunits of Gq-coupled receptors in TRPM8-mediated signaling.
Recently, we have shown that stimulation of TRPM8 channels activates the transcription factor AP-1 [
13,
24]. AP-1 is composed of two basic region leucine zipper (bZIP) transcription factors of the Jun, Fos and ATF families of transcription factors. We asked, which bZIP proteins is involved in the genetic changes in the nucleus after stimulation of TRPM8 channels.
3. Discussion
In this study, we analyzed the TRPM8-induced signaling pathway that induces a change in gene transcription. Several signaling molecules have been identified in recent years [
12,
13,
14,
15], but the description of TRPM8 signaling still contained several gaps and open questions. We focused on the role of phosphatidylinositol 4,5-bisphosphate and trimeric G protein subunits in the regulation of TRPM8 signaling. Finally, we analyzed the impact of c-Jun, a bZIP transcription factor, on TRPM8-induced activation of AP-1.
It has been proposed that most TRP channels, along with other ion channels, are regulated by the lipid signaling molecule phosphatidylinositol 4,5-bisphosphate [
49]. A variety of experimental strategies have been used to test this concept, including pharmacological and genetic methods. The most convincing results were obtained with the use of sophisticated electrogenetic and chemical genetic tools to reduce plasma membrane phosphatidylinositol 4,5-bisphosphate levels by dephosphorylation, including the use of the rapamycin-inducible 4,5-phosphoinositide phosphatase pseudojanin and the voltage-activatable phosphatase ci-VSP. These experiments conclusively demonstrated that activation of TRPM8 and TRPM3 require phosphatidylinositol 4,5-bisphosphate [
19,
20,
21,
41,
50]. Similar results were shown for the voltage-gated Ca
2+ channel Ca
v1.2 [
42]. In contrast, chemical tools might produce questionable results, due to their nonspecific activities. The application of lipids to patch membranes can lead to non-specific physicochemical changes. The addition of MgATP to excised inside-out patches has been used to activate phosphatidylinositol 4-kinase [
41,
50], but may also lead to the activation of other kinases. The compound wortmannin, known as an inhibitor of phosphatidylinositol-3-kinase and myosin light chain kinase, has been used as a phosphatidylinositol 4-kinase inhibitor to decrease the concentration of phosphatidylinositol 4,5-bisphosphate [
3,
16,
21,
41,
50]. In our hands, application of wortmannin did not inhibit TRPM3 signaling at all. Rather, we observed an increase in AP-1 activity after stimulation of TRPM3 channels with pregnenolone sulfate in the presence of 35 μM wortmannin (G.Thiel, unpublished observations). In this study, we used the compound ISA-2011B for inhibiting PIP5K [
27,
28], the main phosphatidylinositol 4,5-bisphosphate-synthesizing enzyme. The results show that administration of this compound strongly reduced signaling mediated by TRPM8 and TRPM3 channels. Administration of ISA-2011B to T611 cells expressing TRPC6 channels also significantly inhibited hyperforin-induced activation of AP-1 (G.Thiel, unpublished observations), supporting the view that PIP5K-catalyzed biosynthesis of phosphatidylinositol 4,5-bisphosphate is essential for the activation of numerous TRP channels. Finally, in this study, we demonstrated that administration of ISA-2011B also strongly reduced signaling through the voltage-gated Ca
v1.2 Ca
2+ channel, confirming the previous suggestion that phosphatidylinositol 4,5-bisphosphate is a cofactor required for full Ca
v1.2 channel activity [
42]. These results put the spotlight on PIP5K as an important regulator of TRP channel signaling via the regulation of phosphatidylinositol 4,5-bisphosphate biosynthesis.
Phosphatidylinositol 4,5-bisphosphate is thought to interact with ion channels via electrostatic interactions or by direct binding to specific binding sites within the channel proteins. Recently published structural data provide a detailed view into the binding of phosphatidylinositol 4,5-bisphosphate to the TRPM8 and TRPM3 channels. Structural data suggest a phosphatidylinositol 4,5-bisphosphate binding site involving the TRP domain, the pre-S1 domain, and the melastatin homology region-4 (MHR4) of the adjacent subunit [
26]. A similar binding site has been proposed for the TRPM3 channel, involving amino acid residues within the pre-S1 segment, the S4-S5 linker and the TRP domain [
50,
51].
Stimulation of Gαq-coupled receptors has been suggested to impair activation of TRPM8 and TRPM3 [
17,
21] via activation of PLCβ, leading to hydrolysis of phosphatidylinositol 4,5-bisphosphate. Similarly, stimulation of TrkA or PDGBβ receptors, which stimulates PLCγ, has been shown to inhibit TRPM8 current [
16,
17]. In these studies, indirect evidence for a direct relationship between receptor stimulation and phosphatidylinositol 4,5-bisphosphate hydrolysis was provided by using translocation of the PLCγ-PH domain from the plasma membrane to the cytoplasm as a biosensor. This translocation assay, i.e. the loss of membrane localization of the biosensor, should be treated with caution [
52]. The PLCγ-PH domain does not specifically bind to phosphatidylinositol 4,5-bisphosphate, but interacts 20-fold more strongly to IP
3 [
52,
53]. Thus, the PLCγ-PH domain could act as an IP
3 sponge and attenuate IP
3-mediated downstream signaling. Much stonger binding to phosphatidylinositol 3,4,5-trisphosphate than to phosphatidylinositol 4,5-bisphosphate has also been reported [
54]. Another study showed that increased intracellular Ca
2+ concentrations, as occurring after stimulation of Gαq-coupled receptors or TRP channels, interfere with PLCγ-PH binding to the membrane [
55]. Decorating the plasma membrane with a PLCγ-PH domain protein may sequester its targets and interfere with the binding of other phosphatidylinositol 4,5-bisphosphate-binding proteins. As a result, intracellular signaling pathways downstream of TRP channels would be disrupted and off-target effects may occur. For example, expression of the PH domain of PLCβ inhibits the activation of PLCβ by Gβγ [
56], the expression of the PH domain of PLCγ1 inhibits the stimulation of PLC by platelet-derived growth factor [
54], and the expression of the PH domain of PLCδ
1 reduced the concentration of PIP5K in the plasma membrane [
57].
In contrast to the hypothesis that activation of Gαq-coupled receptors inhibit TRPM8 activation via a transient reduction of the phosphatidylinositol 4,5-bisphosphate levels, direct binding of the inactive and activated Gαq subunit to TRPM8 channels has been proposed. Activated Gαq forms a complex with TRPM8 channels and in this way directly inhibits activation of TRPM8 after stimulation of Gαq-coupled receptors independently of the downstream PLC pathway [
22]. Overexpression experiments showed that a Gαq mutant very actively inhibited TRPM8 current that lacked intrinsic GTPase activity and was therefore in its active, GTP-bound conformation. Direct binding of TRPM8 and Gαq has also been reported by others [
23]. Furthermore, this study demonstrated that stimulation of TRPM8 leads to dissociation, i.e. activation of trimeric G-proteins and the subsequent activation of PLC.
In this study, we used a genetic approach to inhibit the activity of Gαq. We expressed the regulator of G-protein signaling-2 (RGS2) in the cells, which stimulates the GTPase activity of Gαq and thus inactivates Gαq, which in its GDP-bound state forms a complex with the Gβγ subunits. Expression of RGS2 strongly inhibited the signaling of a Gαq-coupled designer receptor, clearly demonstrating its activity. Similarly, expression of RGS2 strongly inhibited TRPM8 signaling, suggesting that stimulation of TRPM8 requires an activated Gαq subunit. Thus, it is not the activated Gαq that inhibits TRPM8 as suggested [
22], but rather the inactivation of Gαq. Overexpression of RGS2 had no effect on TRPM3 or Ca
v1.2 signaling, indicating clear differences in the regulation of TRPM8 and TRPM3/Ca
v1.2 signaling. Similarly, overexpression of RGS2 was shown to reduce the Ca
2+ and Na
+ current of TRPV6, whereas the activity of TRPV5 channels was unaffected by RGS2 [
58]. Thus, a subset of TRP channels is regulated by an activated Gαq subunit and therefore responds to overexpression of RGS2 (TRPM8, TRPV6), while others are completely inert to RGS2 overexpression and do not require Gαq (TRPM3, TRPV5)
Recently, the TRPM3 ion channel has been shown to be regulated by the Gβγ subunits of trimeric Gq proteins [
41,
44,
45], and a binding site has been proposed [
59]. In this study, we used a pharmacological approach to confirm that the Gβγ subunits modulate the activity of TRPM3 channels. Furthermore, we demonstrated that TRPM8 channels also respond to the Gβγ-inhibitor gallein. However, the proposed Gβγ binding site for TRPM3 is absent in TRPM8, suggesting that the regulatory role of Gβγ to TRPM8 is mediated by other interactions. It is possible that the Gβγ subunits do not interact directly with TRPM8, but regulate the activity of TRPM8 by manipulating the activity of PLCβ. We conclude that TRPM8 channel activity depends on both an activated Gαq subunit and Gβγ subunits.
What role does PLC play in regulating TRPM8 activity and signaling? It has been proposed that many TRP channels “are either activated downstream of the PLC pathway, or modulated by it” [
60]. An influx of Ca
2+ ions through the TRPM8 channel has been shown to activate PLCδ, which regulates TRPM8 activity by inducing a depletion of the phosphatidylinositol 4,5-bisphosphate levels in the plasma membrane [
16]. In contrast, it has been suggested that an activated Gαq-subunit inhibits TRPM8 independently of PLC [
22]. The fact that activation of TRPM8 requires Gβγ and an activated Gαq suggests that PLCβ is subsequently activated, leading to a reduction of the phosphatidylinositol 4,5-bisphosphate concentration. The Gq subunits can simultaneously and independently bind to PLCβ and modulate its activity. Gαq changes the autoinhibition mediated by the X-Y linker of PLCβ, leading to increased
kcat of PLCβ. Gαq could also support the orientation of the catalytic core of the enzyme at the membrane [
61]. The Gβγ subunits activate PLCβ by recruiting it to the membrane, i.e. bringing it closer to its lipid substrate [
62]. However, due to experimental problems and the use of indirect assay systems, it is difficult to quantify the reduction of the phosphatidylinositol 4,5-bisphosphate concentration after PLC activation and to determine the time frame until the original phosphatidylinositol 4,5-bisphosphate concentration is restored by resynthesis from phosphatidylinositol 4-phosphate. Stimulation of Gαq-coupled receptors has been shown to cause only a small, transient decrease in the total amount of phosphatidylinositol 4,5-bisphosphate, which is efficiently replenished by phosphatidylinositol 4,5-bisphosphate-synthesizing enzymes [
63,
64]. Recently, we showed that the C-terminal domain of PLCβ1 and PLCβ3 interacts with plasma membrane targets, most likely phosphatidylinositol 4,5-bisphosphate, and blocks the biological activation of TRPM8 channels [15.]. It has been suggested that about two thirds of the phosphatidylinositol 4,5-bisphosphate pool is sequestered by binding proteins and is not freely available for phosphatidylinositol 4,5-bisphosphate effector proteins [
65]. Therefore, PLCβ enzymes might regulate TRPM8 activation by masking phosphatidylinositol 4,5-bisphosphate with its C-terminal domain. It is tempting to speculate that the binding of Gβγ and Gαq to PLCβ enzymes induces a conformational switch of PLCβ that removes this blockade and allows activation of TRPM8 channels.
The pathway from the plasma membrane to the nucleus ends with the activation of stimulus-responsive transcription factors. In this study, we were able to show that the transcription factor c-Jun is essential for the formation of an active AP-1 complex within the TRPM8-induced signaling. Recently, we have shown that expression of the c-Jun dimerization parter c-Fos is upregulated upon stimulation of TRPM8 [
12]. AP-1 controls numerous biological activities, including the regulation of proliferation, differentiation and cell death [
66]. The outcome often depends on the cell type. TRPM8 is associated with tumor development, for example prostate cancer, colon cancer, and squamous cell carcinoma [
8,
9]. In this context, it is of particular interest to investigate the oncogenic role of the c-Jun within the TRPM8-induced signaling cascade. This also provides an indication of where future studies on c-Jun-regulated genes could be directed.